Moreover, this study opens up a promising path for screening potential drugs for AD by targeting APOE and its downstream pathways, including suppressing lipid droplet formation, lipid peroxidation, and ferroptosis, and enhancing phagocytosis in microglia. Here, APOE is linked to Alzheimer disease.